# ClinicalTrials.gov record NCT00845507

> PeptideScanner retained ClinicalTrials.gov record NCT00845507 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-04-20, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct00845507-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-04-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00845507-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00845507-exenatide-v1.json
- Content SHA-256: `c4dbf2a5f714eb453f2c9870cbb358800b5d9c907c84a770af11de1b5907369e`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00845507 ([`ctg-observation-nct00845507-2018-04-20-9c0942df52af`](#source-ctg-observation-nct00845507-2018-04-20-9c0942df52af))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00845507 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-04-20, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00845507-2018-04-20-9c0942df52af`](#source-ctg-observation-nct00845507-2018-04-20-9c0942df52af))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00845507 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-04-20, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00845507-2018-04-20-9c0942df52af`](#source-ctg-observation-nct00845507-2018-04-20-9c0942df52af))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00845507-2018-04-20-9c0942df52af`](#source-ctg-observation-nct00845507-2018-04-20-9c0942df52af))

## Sources

<a id="source-ctg-observation-nct00845507-2018-04-20-9c0942df52af"></a>
- **ClinicalTrials.gov record NCT00845507 · retained source version 2018-04-20:9c0942df52afce5c82b79ba49084d3e2945c31614c3556c5acd044b5bb6fe61f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00845507) (`ctg-observation-nct00845507-2018-04-20-9c0942df52af`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00845507." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00845507-exenatide-v1.json SHA-256: c4dbf2a5f714eb453f2c9870cbb358800b5d9c907c84a770af11de1b5907369e.